BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8069170)

  • 1. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro.
    Lima ES; Friedman SR; Bastos FI; Telles PR; Friedmann P; Ward TP; des Jarlais DC
    Addiction; 1994 Jun; 89(6):689-98. PubMed ID: 8069170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of drug injection in the spread of HIV in Argentina and Brazil.
    Libonatti O; Lima E; Peruga A; González R; Zacarías F; Weissenbacher M
    Int J STD AIDS; 1993; 4(3):135-41. PubMed ID: 8324042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
    Lima ES; Bastos FI; Telles PR; Friedman SR
    Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.
    Tran SD; Williams AB; Truong HT; Do NH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):283-7. PubMed ID: 9495230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and HIV seropositivity among injecting drug users in Bangkok.
    Choopanya K; Vanichseni S; Des Jarlais DC; Plangsringarm K; Sonchai W; Carballo M; Friedmann P; Friedman SR
    AIDS; 1991 Dec; 5(12):1509-13. PubMed ID: 1814333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk behavior and HIV seroprevalence among injecting drug users in Rio de Janeiro, Brazil.
    Telles PR; Bastos FI; Guydish J; Inciardi JA; Surratt HL; Pearl M; Hearst N
    AIDS; 1997 Sep; 11 Suppl 1():S35-42. PubMed ID: 9376099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil.
    Hacker MA; Friedman SR; Telles PR; Teixeira SL; Bongertz V; Morgado MG; Bastos FI
    Subst Use Misuse; 2005; 40(1):99-123. PubMed ID: 15702651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
    CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities.
    Buchanan D; Tooze JA; Shaw S; Kinzly M; Heimer R; Singer M
    Drug Alcohol Depend; 2006 Feb; 81(3):221-9. PubMed ID: 16171952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
    Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.
    Vanichseni S; Des Jarlais DC; Choopanya K; Friedmann P; Wenston J; Sonchai W; Sotheran JL; Raktham S; Carballo M; Friedman SR
    AIDS; 1993 Jun; 7(6):887-91. PubMed ID: 8363764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indigence, marginalization and HIV infection among Brazilian cocaine users.
    Surratt HL
    Drug Alcohol Depend; 2000 Mar; 58(3):267-74. PubMed ID: 10759037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-infection with malaria and HIV in injecting drug users in Brazil: a new challenge to public health?
    Bastos FI; Barcellos C; Lowndes CM; Friedman SR
    Addiction; 1999 Aug; 94(8):1165-74. PubMed ID: 10615731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
    Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
    Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L
    Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
    Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
    Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streets, drugs, and the economy of sex in the age of AIDS.
    Weeks MR; Grier M; Romero-Daza N; Puglisi-Vasquez MJ; Singer M
    Women Health; 1998; 27(1-2):205-29. PubMed ID: 9640643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in condom behaviors and beliefs among female drug users recruited from two cities.
    Wood MM; Tortu S; Rhodes F; Deren S
    Women Health; 1998; 27(1-2):137-60. PubMed ID: 9640639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of HIV infection among young adult short-term injection drug users.
    Doherty MC; Garfein RS; Monterroso E; Brown D; Vlahov D
    AIDS; 2000 Apr; 14(6):717-26. PubMed ID: 10807195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.